Funny how many ways a letter can be read.My take - the old CPPs...

Funny how many ways a letter can be read.

My take - the old CPPs were amazing but only gained limited commercial interest but the new ones are ‘off the chart’ and they are identifying what the target we should be looking for is - ie 30-60x which I assume is a target they have got from pharma or the SAB members. They have had test tube results well into this range so the in vivo results are worth watching for.

Multiple mentions of IND consistent with strategy set last year - seems all set for approaching the clinic

Pivotal point is ‘mid year’ and no way a $60m company is going to the clinic in a meaningful way so there must be some big investors or partners sitting in the wings ready to go if this hits the targets. 

So I expect data to keep flowing between now and ‘mid year’ and some sort of large scale corporate activity to follow. Still not sure if I will be a part of it as some of my other stocks are proving more interesting but I’ll try and hold out to see if Mr Tribe keeps accumulating - creep rule means another 3% in June which would be telling and consistent with his slow and steady takeover of this company.